Drug intelligence / Profile preview

NORDBIOTIC SKIN

Development stage: Preclinical
Lead developer: Nordic Biotic
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

NORDBIOTIC SKIN is a probiotic dietary supplement formulation developed by Nordic Biotic, specifically designed to target the gut-skin axis for skin health applications. Administered orally, this bacterial strain formulation is intended to modulate microbiome-mediated effects on the skin. It is currently in the preclinical stage of development, with research focusing on functional and in vitro studies to understand its impact on dermatological conditions related to the gut-skin axis. While the specific bacterial strains and molecular mechanisms of action are not yet publicly disclosed, the product represents an emerging approach in microbial therapy that leverages the systemic relationship between intestinal microbiota and skin homeostasis.

Brand names: NORDBIOTIC SKIN
Other names: Nordic Biotic Skin

Beyond the preview

Go deeper on NORDBIOTIC SKIN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NORDBIOTIC SKIN.

Explore the full profile